Caspase-13 Blocking Peptide

Caspase-13 Blocking Peptide

Product No.: C1129

[product_table name="All Top" skus="C1129"]

- -
- -
Target
Evolutionarily Related Interleukin-1 beta Converting Enzyme
Product Type
Blocking Peptide
Alternate Names
ERICE

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 91 to 105 of Human ERICE protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
15 amino acids of human Caspase-13.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
Evolutionarily Related Interleukin-1 beta Converting Enzyme peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

References & Citations

1. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21 2. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC . Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-4 3. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokuhisa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 1999;96:1457-62 (WD0600) 4. Humke EW, Ni J, Dixit VM. ERICE, a novel FLICE-activatable caspase. J Biol Chem 1998;273:15702-7
- -
- -
Prod No.
Description
C1129
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.